Login

BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl 00:00:00

Share On Facebook Share On Twitter

BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Hans Wallenstam Reflects on Wallenstam's Strong Growth and Strategic Future | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
Draig Resources: Reviving High-Grade Gold Exploration in Western Australia
00:10:00
Creating impact at scale for the worlds largest and most influential corporations|Brendan Wallace,Managing Partner,Fifth Wall
00:10:00
From Meteorology to Financial Planning: A Journey Driven by Passion and Helping Others
00:10:00
Strategic Expansion and Strong Financial Outlook at UniCredit | Andrea Orcel, CEO , UniCredit .
00:10:00
Re-architect the world at a molecular level|Mack Healy,Managing Partner,KdT Ventures
00:10:00
The journey to Initialized Capital|Garry Tan,Managing Director, Initialized Capital
00:10:00
Setting Boundaries with Kyle Moore, CFP | Kyle Moore - FOUNDER, FINANCIAL PLANNER of Quarry Hill Advisors
00:10:00
Associates work hard and appreciate that the firm provides meaningful opportunities|Jessica S Carey,Partner,Paul, Weiss, Rifkind, Wharton & Garrison LLP
00:10:00
Gain Therapeutics and Zentalis Pharmaceuticals Forge Innovative Partnership in Multi-Target Oncology Drug Discovery and Development | KIMBERLY BLACKWELL, MD , CHIEF EXECUTIVE OFFICER OF ZENTALIS PHARMACEUTICALS INC
00:00:00
Ergomed announce £25mln acquisition - Miroslav Reljanović, CEO, Ergomed
00:10:00
Thasunda Brown Duckett: A Journey of Resilience and Leadership | Thasunda Brown Duckett, CEO , TIAA.

© 2026 Nehu